However, this has been largely demonstrated in studies of PLHIV initiating treatment in acute stages of HIV infection and/or in moderate immunosuppression (CD4 count > 200cell/cm3 ) [6, 7] effectively leaving a data gap on the population of PLHIV initiated treatment at advanced immunosuppression. The gene discussed is CD4; the disease is HIV infectious disease.